×
About 9,175 results

ALLMedicine™ Herpes Zoster Center

Research & Reviews  2,291 results

Willingness to accept herpes zoster vaccines and the influencing factors in China.
https://doi.org/10.1186/s12879-022-07840-2
BMC Infectious Diseases; Jiang B, Wang Q et. al.

Nov 27th, 2022 - Herpes zoster increases the burden on the elderly in an aging society. Although an effective vaccine licensed by China Food and Drug Administration in 2019 was introduced into the market in June 2020, the willingness and influencing factors of her...

Fear of falling as a potential complication of Ramsay Hunt syndrome in older adults: a ...
https://doi.org/10.1186/s12877-022-03606-2
BMC Geriatrics; Chou CC, Lo YT et. al.

Nov 27th, 2022 - Fear of falling (FOF) is a common and major health concern in older adults. The consequences of FOF include reduced physical performance, social activity, and health-related quality of life. Ramsay Hunt syndrome (RHS) is a herpes zoster-related fa...

Longitudinal changes in cell-mediated immunity after varicella-zoster virus skin test i...
https://doi.org/10.1002/jmv.28336
Journal of Medical Virology; Ikeda D, Imano H et. al.

Nov 24th, 2022 - Varicella-zoster virus-specific cell-mediated immunity has been associated with the onset and severity of herpes zoster (HZ), and the administration of the HZ vaccine enhanced the immunity. However, limited data is available on the duration of cel...

Headache After Vaccination: An Update on Recent Clinical Trials and Real-World Reporting.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685066
Current Pain and Headache Reports; Garces KN, Cocores AN et. al.

Nov 24th, 2022 - The aim of this review is to characterize headache as a vaccine adverse event (VAE) in clinical trials. Of the recent phase III vaccine RCTs (non-COVID-19), 53 studies reported on headache (13 infectious agents). The median rate (interquartile ran...

Chronic obstructive pulmonary disease is associated with an increased risk of herpes zo...
https://doi.org/10.1111/crj.13554
The Clinical Respiratory Journal; Thompson-Leduc P, Ghaswalla P et. al.

Nov 24th, 2022 - Chronic obstructive pulmonary disease (COPD) has been reported as a potential risk factor for developing herpes zoster (HZ). We aimed at comparing incidence rates of HZ between people with versus without COPD in the US. This retrospective cohort s...

see more →

Guidelines  6 results

Assessment of Herpes Zoster Risk Among Recipients of COVID-19 Vaccine
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2798504
JAMA Network Open; Akpandak I, Miller DC et. al.

Nov 16th, 2022 - The rapid production and distribution of COVID-19 vaccines have been key measures in reducing the burden of disease associated with SARS-CoV-2 infection. As millions of US residents complete their COVID-19 primary immunization series and receive a...

Management of herpesvirus reactivations in patients with solid tumours and hematologic ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810475
Annals of Hematology; Henze L, Buhl C et. al.

Jan 8th, 2022 - Clinical reactivations of herpes simplex virus or varicella zoster virus occur frequently among patients with malignancies and manifest particularly as herpes simplex stomatitis in patients with acute leukaemia treated with intensive chemotherapy ...

European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by...
https://doi.org/10.1111/jdv.13957
Journal of the European Academy of Dermatology and Venere... Werner RN, Nikkels AF et. al.

Nov 3rd, 2016 - Herpes zoster (HZ, shingles) is a frequent medical condition which may severely impact the quality of life of affected patients. Different therapeutic approaches to treat acute HZ are available. The aim of this European project was the elaboration...

Interventional management of neuropathic pain: NeuPSIG recommendations.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484720
Pain References; Dworkin RH, O'Connor AB et. al.

Jun 12th, 2013 - Neuropathic pain (NP) is often refractory to pharmacologic and noninterventional treatment. On behalf of the International Association for the Study of Pain Neuropathic Pain Special Interest Group, the authors evaluated systematic reviews, clinica...

Vaccines for measles, mumps, rubella, varicella, and herpes zoster: immunization guidel...
https://www.ncbi.nlm.nih.gov/pubmed/22086887
The Journal of the American Osteopathic Association; Hendriksz T, Malouf P et. al.

Dec 7th, 2011 - Although vaccinations are most commonly associated with the pediatric population, it is important for healthcare professionals to be familiar with the vaccines that are recommended for adults. The authors discuss 3 vaccines-the measles, mumps, and...

see more →

Drugs  643 results see all →

Clinicaltrials.gov  163 results

Assessment of Herpes Zoster Risk Among Recipients of COVID-19 Vaccine
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2798504
JAMA Network Open; Akpandak I, Miller DC et. al.

Nov 16th, 2022 - The rapid production and distribution of COVID-19 vaccines have been key measures in reducing the burden of disease associated with SARS-CoV-2 infection. As millions of US residents complete their COVID-19 primary immunization series and receive a...

Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency
https://clinicaltrials.gov/ct2/show/NCT01176006

Oct 14th, 2022 - Background Mutations in the Dedicator of Cytokinesis-8 (DOCK8) gene are responsible for an immunodeficiency disease characterized by: severe cutaneous and sinopulmonary infections with bacterial organisms; extensive cutaneous viral infections with...

Vitamin C as add-on Therapy in Patients With Acute Herpes Zoster
https://clinicaltrials.gov/ct2/show/NCT05561257

Oct 6th, 2022 - To compare the efficacy and tolerability of three different doses of Pascorbin® besides standard medication with placebo and the reduction of herpes zoster-associated clinical symptoms as an add-on therapy for patients suffering from acute herpes ...

A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Su...
https://clinicaltrials.gov/ct2/show/NCT02723773

Oct 4th, 2022 - This is the long-term follow-up study (ZOE-LTFU) of studies 110390 and 113077 (ZOSTER-006/022) to assess the prophylactic efficacy, safety, and immunogenicity persistence of GSK Biologicals' Herpes Zoster subunit (HZ/su) vaccine and will include a...

A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults
https://clinicaltrials.gov/ct2/show/NCT05371080

Sep 30th, 2022 - The purpose of the current ZOSTER-101 long-term follow-up (LTFU) study of ZOSTER-049 (NCT02723773) study, an extension of ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) primary studies, is to assess the long-term vaccine efficacy (VE) again...

see more →

News  547 results

Cilta-cel Induces Strong Response in Chinese Patients With Relapsed/Refractory Multiple Myeloma
https://www.onclive.com/view/cilta-cel-induces-strong-response-in-chinese-patients-with-relapsed-refractory-multiple-myeloma

Nov 21st, 2022 - Ciltacabtagene autoleucel (cilta-cel; Carvykti) produced early, deep, and durable responses in patients with relapsed/refractory multiple myeloma (RRMM) treated at 8 sites in China.1 Investigators said the results from the pivotal phase 2 CARTIFAN...

IBD and Preterm Birth Risk; Leprosy Bacteria Promote Liver Growth; COVID and IBD
https://www.medpagetoday.com/gastroenterology/generalgastroenterology/101812

Nov 17th, 2022 - Histological inflammation and clinical disease activity in inflammatory bowel disease (IBD) were risk factors for preterm birth, especially in the case of ulcerative colitis. (eClinicalMedicine) Leprosy-causing bacteria (Mycobacterium leprae) prom...

Large U.S. Study Finds No Link Between COVID Vaccine and Shingles
https://www.medpagetoday.com/infectiousdisease/covid19vaccine/101790

Nov 16th, 2022 - No association was detected between COVID-19 vaccination and herpes zoster infection in a database study involving more than 2 million individuals in the U.S. Using a self-controlled risk interval (SCRI) analysis, the risk of herpes zoster in the ...

Assessment of Herpes Zoster Risk Among Recipients of COVID-19 Vaccine
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2798504
JAMA Network Open; Akpandak I, Miller DC et. al.

Nov 16th, 2022 - The rapid production and distribution of COVID-19 vaccines have been key measures in reducing the burden of disease associated with SARS-CoV-2 infection. As millions of US residents complete their COVID-19 primary immunization series and receive a...

Neoantigen TCR T-cell Therapy Shows Early Proof-of-Concept in Solid Tumors
https://www.onclive.com/view/neoantigen-tcr-t-cell-therapy-shows-early-proof-of-concept-in-solid-tumors

Nov 10th, 2022 - A personalized neoantigen-specific and off-the-shelf T cell receptor (TCR) T-cell therapy utilized through CRISPR gene editing technology demonstrated feasibility and tolerability in 16 patients across multiple tumor types, according to first-in-h...

see more →

Patient Education  20 results see all →